MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcchd.2026.100653

Медицинская библиотека · International journal of cardiology. Congenital heart disease · 2026

Evaluating the effect of renin-angiotension-aldosterone system inhibitors and beta blockers on the progression of bicuspid aortic valve aortopathy in adulthood: A retrospective cohort study.

Schamroth Pravda Nili, Samuel Elchanan, Bental Tamir, Brem Ofir, Richter Ilan, Skalsky Keren, Schamroth Pravda Miri, Shapira Yaron, Kornowski Ran, Witberg Guy

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Patients with a bicuspid aortic valve (BAV) often have an associated aortopathy and increased risk of aortic dissection. This study aimed to assess if the chronic use of renin-angiotensin-aldosterone system inhibitors (RAASi) or beta blockers (BB) may be associated with reducing the progression of aortic dilation in adult BAV patients.

METHODS

A retrospective cohort study was performed including adult patients with BAV with serial echocardiography over ≥5 years. The cohort was subdivided according to chronic use of RAASi or BB. The primary outcome was a composite of progression of absolute ascending aortic diameter ≥4.5 cm or surgery for ascending aortic replacement.

RESULTS

Included were 262 patients with mean age of 54.3 ± 19.5 years and 75.1 % male. The average follow-up time was 10.8 ± 0.8 years. The cumulative incidence of the primary endpoint was 14.6 % at 10-year follow up and 33.3 % at 15-year follow up. While those with RAASi (n = 39) had the primary endpoint numerically less that those without RAASi chronic therapy (12.8 % vs 24.8 %, p = 0.147), on multivariate analysis there was no significant decreased risk for the primary outcome. (HR = 0.89, 95 % CI [0.34-2.86], p = 0.97). Similarly, there was no significant decreased risk of the primary outcome amongst those with chronic beta blocker use following multivariate analysis (HR = 0.96, 95 % CI [0.37-2.51], p = 0.95).

CONCLUSIONS

Our findings suggest that the chronic use of RAASi or BB was not associated with a blunted progression of BAV aortopathy in the adult population. These results highlight the need for larger, randomised studies to validate these observations and further explore potential preventative strategies in this population.

Для цитирования: Schamroth Pravda Nili, Samuel Elchanan, Bental Tamir, Brem Ofir, Richter Ilan, Skalsky Keren, Schamroth Pravda Miri, Shapira Yaron, Kornowski Ran, Witberg Guy. Evaluating the effect of renin-angiotension-aldosterone system inhibitors and beta blockers on the progression of bicuspid aortic valve aortopathy in adulthood: A retrospective cohort study.. International journal of cardiology. Congenital heart disease. 2026. DOI: 10.1016/j.ijcchd.2026.100653.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.